Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 190,405 | 0 | 0 | 0 | 0 |
| Cost of Goods | 2,700 | N/A | N/A | N/A | N/A |
| Gross Profit | 187,705 | N/A | N/A | N/A | N/A |
| Operating Expenses | 178,991 | 187,671 | 41,384 | 24,397 | 31,528 |
| Operating Income | 9,414 | -187,671 | -41,384 | -24,397 | -31,528 |
| Interest Expense | 5,476 | 231 | 0 | 0 | 0 |
| Other Income | 16,952 | 12,052 | 2,396 | 330 | 618 |
| Pre-tax Income | 20,890 | -175,850 | -38,988 | -24,067 | -30,910 |
| Net Income Continuous | 20,890 | -175,850 | -38,988 | -24,067 | -30,910 |
| Net Income | $20,890 | $-175,850 | $-38,988 | $-24,067 | $-30,910 |
| EPS Basic Total Ops | 0.40 | -4.38 | -2.36 | -2.87 | -5.81 |
| EPS Basic Continuous Ops | 0.41 | -4.38 | -2.36 | -2.87 | -5.81 |
| EPS Diluted Total Ops | 0.39 | -4.38 | -2.36 | -2.87 | -5.81 |
| EPS Diluted Continuous Ops | 0.40 | -4.38 | -2.36 | -2.87 | -5.81 |
| EPS Diluted Before Non-Recurring Items | N/A | -4.38 | -2.36 | -2.87 | -6.00 |
| EBITDA(a) | $11,466 | $-185,684 | $-39,426 | $-22,433 | $-29,565 |